Sarah Cannon Research Institute (SCRI)

Sarah Cannon Research Institute is a leading global oncology research organization.
It conducts community-based clinical trials, advancing patient therapies for three decades.
SCRI has conducted over 850 first-in-human clinical trials.
Its pivotal research contributed to most new FDA-approved cancer treatments in the past decade.
A network of 1,300 physicians enrolls patients across 200 sites in over 20 U.S. states.